Emerging risk factors for stroke. What have we learned from Mendelian randomization studies?

Emerging risk factors for stroke. What have we learned from Mendelian randomization studies?

Bibliographic Details
Main Authors:	Hopewell, J, Clarke, R
Format:	Journal article
Published:	American Heart Association 2016

Similar Items

RECURRENT STROKE: WHAT HAVE WE LEARNT?
by: EM Khoo, et al.
Published: (2007-01-01)

What have we learned?
by: Peter Rodgers, et al.
Published: (2021-12-01)

Stroke care in Spain. What do we have? What do we need?
by: E. Díez-Tejedor, et al.
Published: (2011-10-01)

Relative effects of LDL-C on ischemic stroke and coronary disease: A Mendelian randomization study
by: Valdes-Marque, E, et al.
Published: (2019)

Chernobyl and Fukushima nuclear accidents: What have we learned and what have we done?
by: Đurović Branka, et al.
Published: (2016-01-01)

Risk factors for immune-related adverse events: what have we learned and what lies ahead?
by: Xiaoyan Liu, et al.
Published: (2021-11-01)

GOAL: What Have We Learned?
by: Leek Timothy
Published: (2005-09-01)

What have we learned from the pandemic?
by: Iêda Maria Barbosa Aleluia
Published: (2021-03-01)

Introduction. Emerging infections: what have we learnt from SARS?
by: Mclean, A, et al.
Published: (2004)

Emerging infections: What have we learnt from SARS - Introduction
by: Mclean, A, et al.
Published: (2004)

Recanalization and reperfusion therapies of acute ischemic stroke: what have we learned, what are the major research questions, and where are we headed?
by: Meritxell eGomis, et al.
Published: (2014-11-01)

What have we learned? : ten years on /
by: Ashkanasy, Neal M., 1945-, et al.
Published: (2011)

Orthopaedic infections: what have we learned?
by: Christopher Lee, MD, et al.
Published: (2023-05-01)

Development Economics: What Have We Learned?
by: Jagdish N. Bhagwati
Published: (1984-01-01)

Phage Therapy: What Have We Learned?
by: Andrzej Górski, et al.
Published: (2018-05-01)

COVID-19: what have we learned?
by: Yeh-Li Ho, et al.
Published: (2020-06-01)

What we have learned from the Myriad trials.
by: Hendrix, S, et al.
Published: (2009)

What Have We Not Learned from the Convergence Debate?
by: Leone Leonida
Published: (2023-04-01)

What we have learned from the Rigopiano tragedy
by: Antonella Pescini, et al.
Published: (2019-12-01)

Aura and Stroke: relationship and what we have learnt from preclinical models
by: Muge Yemisci, et al.
Published: (2019-05-01)

PTH Assays: Understanding What We Have and Forecasting What We Will Have
by: Jose Gilberto H. Vieira
Published: (2012-01-01)

Leukemia and risk of stroke: a Mendelian randomization analysis
by: Xiaoyao Yi, et al.
Published: (2025-02-01)

A modeling dialog with AI – what do we learn about what we have to learn?
by: Joolingen, Wouter van
Published: (2024)

Vascular Endothelial Growth Factor and Ischemic Stroke Risk: A Mendelian Randomization Study
by: Zhang, X, et al.
Published: (2024)

The Gonadotropin-Inhibitory Hormone: What We Know and What We Still Have to Learn From Fish
by: María P. Di Yorio, et al.
Published: (2019-02-01)

What have we learned from brucellosis in the mouse model?
by: Grilló María-Jesús, et al.
Published: (2012-04-01)

What we have learned from COVID-19 pandemic?
by: Hsiu-Hsi Chen, et al.
Published: (2021-06-01)

Development and democracy : what have we learned and how? /
by: Hyden, Goran, et al.
Published: (2002)

Fifty Years of the Hypotelminorheic: What Have We Learned?
by: Tanja Pipan, et al.
Published: (2012-12-01)

The COVID-19 challenge. What have we learned?
by: Adrian Ceccato, et al.
Published: (2022-11-01)

The pilocarpine model of epilepsy: what have we learned?
by: Fulvio A. Scorza, et al.
Published: (2009-09-01)

The infrared Galactic disk: What have we learned?
by: Churchwell E.
Published: (2012-02-01)

Lymphopenia in Esophageal Cancer: What Have We Learned?
by: Jia-Lin Wang, et al.
Published: (2021-03-01)

COVID-19 pandemic. What have we learned?
by: Cristina Calvo, et al.
Published: (2021-11-01)

The economics of agricultural development: what have we learned?
by: Roumasset James
Published: (2006-07-01)

COVID-19 pandemic – What have we learned?
by: Manjunath Premanath
Published: (2021-01-01)

Five decades of Fontan palliation: What have we learned? What should we expect?
by: Adil Hassan, et al.
Published: (2023-10-01)

Tegumentary leishmaniasis in the State of Amazonas: what have we learned and what do we need?
by: Jorge Augusto de Oliveira Guerra, et al.
Published: (2015-06-01)

Nonalcoholic fatty liver disease: What do we know and what will we have to learn?
by: N I Volkova, et al.
Published: (2017-02-01)

ASICs in PET: what we have and what we need
by: Vanessa Nadig, et al.
Published: (2025-02-01)